Barcode Diagnostics

Barcode Diagnostics Overview

Founded 2017
Status Private
Latest Deal Type Seed
Latest Deal Amount $800K
Latest Deal Amount
Investors 2

Barcode Diagnostics General Information


Developer of a medical monitoring device designed to be used for personalized cancer drug screening tests. The company's device screens multiple chemotherapy drugs simultaneously in order to assess the efficacy of the treatment on the tumor within the patient's body, enabling physicians to track the drug efficacy on different cell types within the tumor to facilitate optimal drug selection efficiently.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Primary Office
  • Wadi el-Haj Street 13
  • Nazareth Illit 17111
  • Israel
+972 00-000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Barcode Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 12-Jun-2017 $800K 00000 Completed Generating Revenue

Barcode Diagnostics Executive Team (3)

Name Title Board Seat Contact Info
Ronen Eavri Ph.D Co-Founder and Chief Executive Officer
Annie Sabbah Ph.D Co-Founder and Chief Technology Officer
Avi Schroeder Ph.D Co-Founder and Scientific Consultant

Barcode Diagnostics Board Members (2)

Name Representing Role Since
Aharon Schwartz Ph.D Self Board Member 000 0000
Zohar Gendler Self Board Member 000 0000

Barcode Diagnostics Investors (2)

To view Barcode Diagnostics‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Israel Innovation Authority Government Minority 000 0000 000000 0
Next Generation Technology Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial